The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Fear of recurrence in long-term cancer survivors—Do cancer type, sex, time since diagnosis, and social support matter?
Abstract
OBJECTIVE: Fear of recurrence (FoR) is among the most important concerns for cancer survivors. Studies on potentially influencing variables, like time since diagnosis, cancer type, and sex, have yielded heterogeneous results. Also social support has rarely been examined as an influencing factor. This study aims to increase knowledge on these factors. METHOD: Analyses are based on cross-sectional data of long-term survivors of breast, colorectal, and prostate cancer (5-16 years postdiagnosis), recruited by 6 German population-based cancer registries. Six thousand fifty-seven women and men were included in the analyses. FoR was assessed using the short form of the Fear of Progression Questionnaire (FoP-Q-SF). The associations of cancer type, age, sex, time since diagnosis, and social support with moderate/high FoR were identified via multiple logistic regression analyses. RESULTS: The majority of long-term cancer survivors reported experiencing FoR, mostly in low intensity. Female survivors, survivors ≤54 or 55-59 years of age, 5 to 7 years postdiagnosis, with a lower education, with recurrence/metastases, or being socially isolated were at greater risk to experience moderate/high FoR. Cancer type and stage at diagnosis did not reach statistical significance. CONCLUSION: Our results indicate a potential vulnerability for women to experience FoR in moderate/high severity. Also younger and socially isolated survivors were at greater risk to suffer from moderate/high levels of FoR and should thus be monitored for high levels of FoR and be offered the support needed to manage their fears. (PsycINFO Database Record
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Lubben, J., Blozik, E., Gillmann, G., Iliffe, S., von Renteln Kruse, W., Beck, J. C., & Stuck, A. E. (2006) · The Gerontologist · doi:10.1093/geront/46.4.503 · Cited by 2,123
Global prevalence of anxiety disorders: a systematic review and meta-regression
Baxter, A. J., Scott, K. M., Vos, T., & Whiteford, H. A. (2013) · Psychological Medicine · doi:10.1017/s003329171200147x · Cited by 1,537
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217
Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511
Self-citationVickberg, S. M. J. (2003) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2501_03 · Cited by 468
Factors reported to influence fear of recurrence in cancer patients: a systematic review
Crist, J. V., & Grunfeld, E. A. (2013) · Psycho-Oncology · doi:10.1002/pon.3114 · Cited by 431
Fear of cancer progression and cancer‐related intrusive cognitions in breast cancer survivors
Mehnert, A., Berg, P., Henrich, G., & Herschbach, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1481 · Cited by 354
Development, feasibility and performance of a health risk appraisal questionnaire for older persons
Stuck, A. E., Kharicha, K., Dapp, U., Anders, J., von Renteln-Kruse, W., Meier-Baumgartner, H. P., Harari, D., Swift, C. G., Ivanova, K., Egger, M., et al. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-1 · Cited by 324
Multiple Imputation Using SAS Software
Yuan, Y. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i06 · Cited by 314
Koch, L., Bertram, H., Eberle, A., Holleczek, B., Schmid-Höpfner, S., Waldmann, A., Zeissig, S. R., Brenner, H., & Arndt, V. (2014) · Psycho-Oncology · doi:10.1002/pon.3452 · Cited by 253
Self-citation
Cited by
Anxiety and Depression in Cancer Survivors
Yi, J. C., & Syrjala, K. L. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.06.005 · Cited by 389
Lebel, S., Mutsaers, B., Tomei, C., Leclair, C. S., Jones, G., Petricone-Westwood, D., Rutkowski, N., Ta, V., Trudel, G., Laflamme, S. Z., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234124 · Cited by 203
Bishop, M., Rumrill, P. D., Livneh, H., & Martz, E. (2025) · The Oxford Handbook of Rehabilitation Psychology · doi:10.1093/oxfordhb/9780197525456.013.0001 · Cited by 180
Johns, S. A., Stutz, P. V., Talib, T. L., Cohee, A. A., Beck‐Coon, K. A., Brown, L. F., Wilhelm, L. R., Monahan, P. O., LaPradd, M. L., Champion, V. L., et al. (2020) · Cancer · doi:10.1002/cncr.32518 · Cited by 141
“Characterized by maladaptive coping, intrusive thoughts, and excessive distress,(4) clinically significant FCR disproportionally affects breast cancer survivors (BCS) compared with survivors of other common cancers.(5,6) Although approximately 90% of the 3.”
BackgroundAlmeida, S. N., Elliott, R., Silva, E. R., & Sales, C. M. D. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.12.001 · Cited by 116
Fear of Progression in Cancer Patients and Survivors
Dinkel, A., & Herschbach, P. (2018) · Recent Results in Cancer Research · doi:10.1007/978-3-319-64310-6_2 · Cited by 114
Return to work after cancer. A multi-regional population-based study from Germany
Arndt, V., Koch‐Gallenkamp, L., Bertram, H., Eberle, A., Holleczek, B., Pritzkuleit, R., Waldeyer‐Sauerland, M., Waldmann, A., Zeißig, S. R., Doege, D., et al. (2019) · Acta Oncologica · doi:10.1080/0284186x.2018.1557341 · Cited by 107
“Study details have been reported elsewhere [11].”
Self-citationWorry in Thyroid Cancer Survivors with a Favorable Prognosis
Papaleontiou, M., Reyes‐Gastelum, D., Gay, B. L., Ward, K. C., Hamilton, A. S., Hawley, S. T., & Haymart, M. R. (2019) · Thyroid · doi:10.1089/thy.2019.0163 · Cited by 99
“Additionally, cancer-related worry can have emotional and social consequences causing significant disruption in survivors’ functional status (1,3).”
BackgroundFear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?
Bergerot, C. D., Philip, E. J., Bergerot, P. G., Siddiq, N., Tinianov, S., & Lustberg, M. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100031 · Cited by 90
Ban, Y., Li, M., Yu, M., & Wu, H. L. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01816-7 · Cited by 111
Pang, C., & Humphris, G. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.640866 · Cited by 59
Dowers, E., White, C., Cook, K., & Kingsley, J. (2020) · International Journal of Transgender Health · doi:10.1080/26895269.2020.1771805 · Cited by 69
Niu, L., Liang, Y., & Niu, M. (2019) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13978 · Cited by 57
“patients are usually poor, so they are more fearful of the recurrence and metastasis of the cancer.(19,40) Consistent with other studies,(19,41) we found that”
ResultLiu, Z., Thong, M. S. Y., Doege, D., Koch‐Gallenkamp, L., Bertram, H., Eberle, A., Holleczek, B., Waldmann, A., Zeißig, S. R., Pritzkuleit, R., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01473-z · Cited by 63
“Data collection was conducted from August 2009 until April 2011 by postal questionnaires [22].”
MethodSelf-citationLi, Y., Fang, C., Xiong, M., Hou, H. B., Zhang, Y., & Zhang, C. (2023) · Journal of Advanced Nursing · doi:10.1111/jan.16009 · Cited by 59
Social constraints and fear of recurrence in couples coping with early stage breast cancer.
Soriano, E. C., Pasipanodya, E. C., LoSavio, S. T., Otto, A. K., Perndorfer, C., Siegel, S. D., & Laurenceau, J. (2018) · Health Psychology · doi:10.1037/hea0000649 · Cited by 56
Lim, E., & Humphris, G. M. (2020) · Cancer Reports · doi:10.1002/cnr2.1235 · Cited by 61
Fear of cancer recurrence and PSA anxiety in patients with prostate cancer: a systematic review
James, C., Brunckhorst, O., Eymech, O., Stewart, R. J., Dasgupta, P., & Ahmed, K. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-06876-z · Cited by 53
Krok‐Schoen, J. L., Naughton, M. J., Bernardo, B. M., Young, G. S., & Paskett, E. D. (2018) · Psycho-Oncology · doi:10.1002/pon.4731 · Cited by 48
The FCR‐1: Initial validation of a single‐item measure of fear of cancer recurrence
Rudy, L., Maheu, C., Körner, A., Lebel, S., & Gélinas, C. (2020) · Psycho-Oncology · doi:10.1002/pon.5350 · Cited by 45
“As well, the demographic characteristics age and level of education have been found to correlate with FCR in previous studies.(12,13) Younger age and lower level of education were hypothesized to correlate with higher scores on the FCR-1.”
BackgroundResultSauer, C., Weis, J., Faller, H., Junne, F., Hönig, K., Bergelt, C., Hornemann, B., Stein, B., Teufel, M., Goerling, U., et al. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1631471 · Cited by 39
“Since the diagnosis notification affects the disease management and treatment, high PS at those times presumably help prevent recurrence fears [36] and strengthen the patients’ coherence sense, an important determinant of acceptance [37]; however, during this ‘diagnosis shock’, both positive and negative aspects of so…”
ResultCurrent directions in research and treatment of fear of cancer recurrence
Sharpe, L., Thewes, B., & Butow, P. (2017) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000288 · Cited by 37
“However, in large samples of cancer patients, time since diagnosis or treatment fails to predict FCR [1,2].”
BackgroundSebri, V., Triberti, S., & Pravettoni, G. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.607514 · Cited by 39
“Yet, breast cancer patients may develop fear to think and dream about the future, being focused on their self-representation as patients only (Koch-Gallenkamp et al., 2016; Sansom-Daly et al., 2018).”
BackgroundMuldbücker, P., Steinmann, D., Christiansen, H., de Zwaan, M., & Zimmermann, T. (2020) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2020.1762823 · Cited by 37
Palas, J. M. C., Hyland, K. A., Nelson, A. M., Small, B. J., Jim, H., & Jacobsen, P. B. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05552-4 · Cited by 46
“Contrary to hypotheses, social support was not associatedwith FCR, although previous findings on this relationship are mixed [14, 20, 43].”
ResultBai, X., Ta, N., Gong, G.-H., Zhang, B., & Wei, C. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3123878 · Cited by 38
Krok, D., Telka, E., & Kocur, D. J. (2023) · Annals of Behavioral Medicine · doi:10.1093/abm/kaad067 · Cited by 40
“Perceived social support also predicts patients’ tendency to consider cancer as a challenge, which could be connected with better meaning-making and, consequently, decrease the fear of cancer recurrence [31, 40].”
BackgroundPaperák, P., Javůrková, A., & Raudenská, J. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01277-x · Cited by 31
Sebri, V., Durosini, I., & Pravettoni, G. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1085837 · Cited by 36
“Expected results will be the new possibility of thinking of the future and having positive expectations, adopting adaptive coping styles useful to face the Aisease (Zhang et al., 2010; Koch-Gallenkamp et al., 2016).”
BackgroundFear of cancer progression in patients with stage IA malignant melanoma
Wagner, T., Augustin, M., Blome, C., Forschner, A., Garbe, C., Gutzmer, R., Hauschild, A., Heinzerling, L., Livingstone, E., Loquai, C., et al. (2018) · European Journal of Cancer Care · doi:10.1111/ecc.12901 · Cited by 31
Gehrke, A. K., Lee, S. S., Hilton, K., Ganster, B., Trupp, R., McCullough, C., Mott, E., & Feuerstein, M. (2018) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0668-2 · Cited by 33
Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
Bergerot, C. D., Battle, D. J., Philip, E. J., Bergerot, P. G., Msaouel, P., Smith, A. B., Bamgboje‐Ayodele, A., Shuch, B. M., Derweesh, I., Jonasch, E. W., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00105 · Cited by 28
Oliveri, S., Arnaboldi, P., Pizzoli, S. F. M., Faccio, F., Giudice, A. V., Sangalli, C., Luini, A., & Pravettoni, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.917 · Cited by 28
Cancer Fear, Emotion Regulation, and Emotional Distress in Patients With Newly Diagnosed Lung Cancer
Su, C.-H., Liu, Y., Hsu, H., & Kao, C. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001150 · Cited by 28
“5 6 – 8 Nevertheless, research related to newly diagnosed lung cancer patients ’ cancer fear is scarce.”
BackgroundChen, D., Zhu, J., Xu, Q., Wang, F., Ji, C., Di, H., Yuan, P., Bai, X., & Chen, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2761 · Cited by 22
Nilsson, R., Næss-Andresen, T. F., Myklebust, T. Å., Bernklev, T., Kersten, H., & Haug, E. S. (2021) · European Urology Open Science · doi:10.1016/j.euros.2021.01.002 · Cited by 25
Anxiety and depression risk in Taiwan women with breast cancer and cervical cancer
Yang, C.-M., Sung, F., Mou, C.-H., Liao, C.-H., Wang, P.-H., & Shieh, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.946029 · Cited by 29
Fear of progression among colorectal cancer patients: a latent profile analysis
Hu, C., Weng, Y., Wang, Q., Yu, W., Shan, S., Niu, N., & Chen, Y. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08660-7 · Cited by 31
“This study also found that the higher the utilization of social support by the patients, the less likely they were to experience fear of disease progression, which was consistent with the findings of Koch-Gallenkamp and Bertram (2016) [33].”
Cheli, S., Caligiani, L., Martella, F., Bartolo, P. D., Mancini, F., & Fioretto, L. (2019) · Psycho-Oncology · doi:10.1002/pon.4984 · Cited by 27
Familial aspects of fear of cancer recurrence: current insights and knowledge gaps
Faraji, A., Dehghani, M., & Khatibi, A. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1279098 · Cited by 24
Mindfulness-Based Interventions in Recurrent Ovarian Cancer: A Mixed-Methods Feasibility Study
Arden-Close, E., Mitchell, F., Davies, G., Bell, L., Fogg, C., Tarrant, R., Gibbs, R., & Yeoh, C. C. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735420908341 · Cited by 20
He, J., Xu, H.-Q., Yang, J., Hou, D., Gong, X., Lu, X., Wang, W., Cai, M., Yu, Y., & Gao, J. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1222798 · Cited by 21
“This study’s meta-analysis revealed that Chinese breast cancer patients had a high FoP score of 33.84 (95% CI: 31.91 ~ 35.77), higher than developed countries like Germany (Mehnert et al., 2009; Koch-Gallenkamp et al., 2016).”
BackgroundInfluentialFear of cancer recurrence in lymphoma survivors: A descriptive study
Latella, L. E., Rogers, M., Leventhal, H., Parker, P. A., Horwitz, S. M., Matasar, M. J., Bylund, C. L., Kissane, D. W., Franco, K., & Banerjee, S. C. (2019) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2019.1677840 · Cited by 24
“In this study, we delved deeper into assessing FCR in lymphoma survivors as FCR has been documented in lymphoma patients and associated with survivorship.(8,9,15,16) More specifically, we examined FCR in patients with Hodgkin’s lymphoma (HL) and Diffuse Large B-cell Lymphoma (DLBCL) who have excellent survival rates.”
MethodImpact of caregivers’ negative response to cancer on long-term survivors’ quality of life
Best, A. L., Shukla, R., Adamu, A. M., Tyson, D. M., Stein, K., & Alcaraz, K. I. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05509-7 · Cited by 23
Larsen, C., Kirchhoff, K. S., Saltbæk, L., Thygesen, L. C., Karlsen, R. V., Svendsen, M. N., Høeg, B. L., Horsbøl, T. A., Bidstrup, P. E., Christensen, H. G., et al. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2197122 · Cited by 18
“time [2], FCR has also been found to be the strongest short time after diagnosis and decrease over time [25,26].”
BackgroundBentley, G., Zamir, O., Dahabre, R., Perry, S., Karademas, E. C., Poikonen‐Saksela, P., Mazzocco, K., Sousa, B., & Pat‐Horenczyk, R. (2023) · Cancers · doi:10.3390/cancers15184590 · Cited by 21
Heidkamp, P., Breidenbach, C., Hiltrop, K., Kowalski, C., Enders, A., Pfaff, H., Weltermann, B., Geiser, F., & Ernstmann, N. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06329-z · Cited by 20
Carreira, H., Williams, R., Müller, M., Harewood, R., & Bhaskaran, K. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0551-2 · Cited by 16
“Women must also deal with the fear of cancer recurrence and death [14].”
BackgroundFear of cancer recurrence and social support among Indonesian gynecological cancer survivors
Wijayanti, T., Afiyanti, Y., Rahmah, H., & Milanti, A. (2018) · Archive of oncology · doi:10.2298/aoo180201004w · Cited by 15
Risk Factors for Fear of Recurrence in Head and Neck Cancer Patients
Riggauer, J., Blaser, D., Eliçin, O., Gahl, B., Giger, R., & Mueller, S. A. (2022) · The Laryngoscope · doi:10.1002/lary.30340 · Cited by 17
“On the other hand, studies including various types of cancer agreed that tumor stage and FoR do not correlate.(36,42) This reflects the fact that the severity of symptoms, as perceived by the patients, does not necessarily correspond with objective findings and may in some cases even be an expression of underlying anx…”
BackgroundSources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma
Bergerot, C. D., Battle, D. J., Bergerot, P. G., Dizman, N., Jonasch, E. W., Hammers, H. J., George, D. J., Bex, A., Ljungberg, B., Pal, S. K., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00011 · Cited by 14
“While the prognostic differences may play a slight role in promoting fears pertaining to clinical outcome, there may be underlying psychological differences between males and females that drive this discordance (15, 16).”
BackgroundHassani, S. F., Tizdast, T., & Zarbakhsh, M. R. (2021) · Journal of Client-centered Nursing Care · doi:10.32598/jccnc.7.3.372.1 · Cited by 14
Magnani, C., Smith, A. B., Rey, D., Sarradon‐Eck, A., Préau, M., Bendiane, M., Bouhnik, A., & Mancini, J. (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01193-0 · Cited by 17
“Unlike other studies [18, 45], we found an association between FCR and cancer site.”
ResultHefner, J., Berberich, S., Lanvers, E., Sanning, M., Steimer, A.-K., & Kunzmann, V. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s142784 · Cited by 14
“32, 33 The topic of treatment costs was not dealt with in this questionnaire because of the full monetary treatment coverage by the German health care system and hence remained disregarded.”
Bastian, T., & Burhansstipanov, L. (2020) · JCO Global Oncology · doi:10.1200/jgo.19.00215 · Cited by 13
Li, B., Lin, X., Chen, S., Qian, Z., Wu, H., Liao, G., Chen, H., Kang, Z., Peng, J., & Liang, G. (2024) · BMC Public Health · doi:10.1186/s12889-024-17969-1 · Cited by 13
“Consistent with previous studies [35–38], the high-level FoP group had a lower education level and lower income level than the low-level FoP group.”
ResultShi, Y., Dai, J., Kuai, B.-X., Xiaoqin, S., Yang, R., Gong, S., & Guo, Y. (2023) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2023.100299 · Cited by 14
Life Review Intervention: A Systematic Review of Its Feasibility Among Persons With Cancer
Ng, J. K.-Q., Subramaniam, P., Ismail, F., Ahmad, M., & Shamsudin, N. L. (2022) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2022.07.016 · Cited by 14
Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer
Taylor, M. A., Westvold, S. J., Long, J. B., Hyslop, T., Silber, A. L. M., Forman, R., Yasin, F., Kwaramba, T., Wang, S., Leapman, M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.44812 · Cited by 10
Babadostu, M. K., & Eyrenci, A. (2025) · Psycho-Oncology · doi:10.1002/pon.70076 · Cited by 12
“A number of demographic and clinical variables have been identified as correlates of FCR including younger age [32–34], receiving adjuvant therapy [35, 36] and years since diagnosis and treatment completion [37, 38] However, there is a paucity of data concerning the relationship between FCR and…”
Latent profile analysis of fear of progression in Chinese hematologic malignancy survivors
Liu, Y., Zhang, Q., Zhao, J., Zhang, T., Tian, F., Wang, Z., Shao, Z., Li, X., Xie, W., Yang, F., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-00415-6 · Cited by 12
“Gallenkamp et al. 60 demonstrated that patients who were socially isolated 5 to 7 years post-diagnosis, as well as those with less education or income, were at a greater risk of experiencing moderate to high levels of FoP, which can impact their QoL.”
Guo, J., Shen, Y., Li, B., Wang, F., Jiang, Y., Lin, Y., & Chen, J. (2020) · Medicine · doi:10.1097/md.0000000000019681 · Cited by 13
“Women also have to live in the fear of recurrence of cancer and death.([12]) All these factors may have long-term”
BackgroundButow, P. N., Müller, F., Napier, C. E., Bartley, N., Ballinger, M. L., Biesecker, B. B., Juraskova, I., Meiser, B., Schlub, T. E., Thomas, D. M., et al. (2021) · Psycho-Oncology · doi:10.1002/pon.5764 · Cited by 10
“Fear of cancer recurrence (FCR) or progression (FCP), defined as ‘fear, worry or concern relating to the possibility that cancer will come back or progress’,(1) is a common and distressing concern after a cancer diagnosis, for which patients often seek help.(2) As is clear from the definition above (which includes bot…”
BackgroundLyhne, J. D., Smith, A. B., Timm, S., Simard, S., Jensen, L. H., Frostholm, L., & Fink, P. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08159-7 · Cited by 13
“On average, older long-term cancer survivors report less FCR compared to younger survivors [8], independent of cancer type [7, 9, 10], but high levels of FCR are reported in a small but significant group of older (mean age 77.6 years), long-term (average time since diagnosis 9.5 years) cancer…”
BackgroundMethodInfluentialDoege, D., Thong, M. S. Y., Koch‐Gallenkamp, L., Bertram, H., Eberle, A., Holleczek, B., Waldeyer‐Sauerland, M., Waldmann, A., Zeißig, S. R., Brenner, H., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4317-8 · Cited by 9
Self-citationNguyen, P., Heisey, R., Quenneville, C., Goulbourne, E., Khan, R., Rinaldo, E., Chagigiorgis, H., Shields, R., & Townsley, C. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07148-6 · Cited by 9
RETRACTED: Quality of Life and PTSD Symptoms, and Temperament and Coping With Stress
Burnos, A., & Bargiel-Matusiewicz, K. M. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02072 · Cited by 9
“Patients diagnosed with cancer deal with fear even if the treatment was successful and they are considered cancer survivors (Koch-Gallenkamp et al., 2016).”
BackgroundRetractedLiu, J., Griva, K., & Mahendran, R. (2023) · Annals of Behavioral Medicine · doi:10.1093/abm/kaad023 · Cited by 9
Wang, M., Chen, G., Zhao, J., Li, W., Yu, S., Yao, S., Tang, L., Xu, J., & Cheng, H. (2023) · PubMed Central · Cited by 12
Schneider, J., Hernández, D., CAESAR study group, Schlander, M., Arndt, V., & on behalf of the CEASAR study group (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01293-x · Cited by 9
Self-citationOcalewski, J., Jankowski, M., Zegarski, W., Migdalski, A., & Buczkowski, K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20075416 · Cited by 10
Alkan, A., Yaşar, A., Güç, Z. G., Gürbüz, M., Başoğlu, T., Göksu, S. S., Başal, F. B., Türk, H. M., Özdemir, Ö., Çınkır, H. Y., et al. (2020) · European Journal of Cancer Care · doi:10.1111/ecc.13296 · Cited by 9
Liu, C., Liu, C., Gao, H., Yu, X., Chen, C., Lin, H., Qiu, L., Chen, L., & Tian, H. (2023) · Asian Nursing Research · doi:10.1016/j.anr.2023.11.002 · Cited by 9
Marziliano, A. M., Byakova, A., Patel, P., Herman, S. W., & Diefenbach, M. A. (2024) · International Journal of Behavioral Medicine · doi:10.1007/s12529-024-10286-2 · Cited by 7
Reskati, M. H., Elyasi, F., Hosseini, S. H., Shafizad, M., Hedayatizadeh‐Omran, A., Alizadeh‐Navaei, R., Khosravi, S., Kolaei, M. A. M., Froelicher, E. S., & Nia, H. S. (2022) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-022-00875-3 · Cited by 7
“Research on FoP in patients with cancer is rapidly growing [15–19].”
BackgroundPark, S. K., & Min, Y. H. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1170077 · Cited by 7
“, 2022), lower age (Crist and Grunfeld, 2013; Simard et al., 2013; Koch-Gallenkamp et al., 2016; Guo et al., 2022; Luigjes-Huizer et al., 2022), lower education level (KochGallenkamp et al.”
BackgroundQuality of life in cancer as a function of temperament, coping and posttraumatic stress disorder
Laskowska, A. (2018) · Current Psychology · doi:10.1007/s12144-018-0008-3 · Cited by 6
“Patients diagnosed deal with fear even if the treatment was successful and they are considered cancer survivors (Koch-Gallenkamp et al. 2016).”
BackgroundAndreis, F., Mirandola, M., Deori, C., Ferrari, C., Meriggi, F. A., & Zaniboni, A. (2025) · Palliative & Supportive Care · doi:10.1017/s1478951525101016 · Cited by 8
“Consistent with prior research (Koch-Gallenkamp et al. 2016; Simard and Savard 2015), our analysis revealed that women tend to report higher levels of FCR than men.”
Heshmati, R., Kheiriabad, M., Azmoodeh, S., Ghasemi, A., & Pfaltz, M. C. (2023) · Journal of Interpersonal Violence · doi:10.1177/08862605231218678 · Cited by 6
“…various areas relevant to health and mental health management, including adherence to treatments (Kondylakis et al., 2017), views on the future (Koch-Gallenkamp et al., 2016; Sansom-Daly et al., 2018; Zhang et al., 2010), daily lifestyle and relationships (Jacobs et al., 2018), emotion…”
BackgroundNuseibeh, B. Z., Hoy, M. S., Panoch, J., Gowan, T. M., Buckles, D. M., Schwarz, M. E., & Johns, S. A. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08976-4 · Cited by 7
“Eligibility was capped at 5 years post-treatment based on findings of time since diagnosis beyond 5–7 years associated with lower FCR [28].”
Taylor, R. A., Bakitas, M. A., Wells, R. D., Dionne-Odom, J. N., Kennedy, R., Williams, G. R., Frank, J., & Li, P. (2023) · Cancer Medicine · doi:10.1002/cam4.6850 · Cited by 4
Greinacher, A., Kuehl, R., Mai, E. K., Goldschmidt, H., Wiskemann, J., Fleischer, A., Rasche, L., Dapunt, U., & Maatouk, I. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05570-9 · Cited by 5
“Studies suggest that PS reduces reoccurrence anxiety (Koch-Gallenkamp et al. 2016) and strengthens patients’ sense of coherence (Pasek et al. 2017).”
BackgroundCancer as a chronic disease — a psychological perspective
Paleczna, M. (2018) · Nowotwory Journal of Oncology · doi:10.5603/njo.2018.0006 · Cited by 5
“Thus, patients experience a fear of recurrence [55, 56] in various types of cancer: breast cancer [57, 58], ovarian cancer [59], prostate cancer [60, 61], head and neck cancer [62, 63], thyroid cancer [64], hematological cancer [65], gastric cancer [66] colorectal cancer [67], oral cancer [68].”
BackgroundNia, H. S., Sobhanian, P., Froelicher, E. S., Farhadi, B., Hejazi, S. S., Goudarzian, A. H., Mohammadinezhad, M., Zaboli, E., Hosseinian, M. M., Reskati, M. H., et al. (2024) · Health Science Reports · doi:10.1002/hsr2.2260 · Cited by 4
“8,9 Recognizing the significance of addressing fear in breast cancer patients, a range of tools have been developed and made available for investigation, one of which is the fear of progression questionnaire ‐ short form (FoP ‐”
BackgroundWu, J., Cao, Y., Yao, L., Chen, L., & Xu, L. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06344-1 · Cited by 3
“This observation is broadly consistent with international evidence demonstrating that insufficient sup - port and greater social constraints are associated with elevated FCR and poorer quality of life (Ajmera et al. 2025; Koch-Gallenkamp et al. 2016 ; Mikrut et al. 2020 ).”
Ho, S., Palka, J. M., Mersch, J. A., Martin, W. B., & Howe‐Martin, L. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01479-x · Cited by 3
“Koch-Gallenkamp and colleagues reported that socially isolated survivors endorsed higher levels of FCR than their socially connected counterparts [23 ].”
Zare, F., Hekmat, K., Afshari, P., Amanelahi, A., Haghighizadeh, M. H., & Razmjoo, S. (2025) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc-149108 · Cited by 3
Sousa, M. C., Moreira, H., Melo, C., Canavarro, M. C., & Carvalho, C. B. (2021) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2021.101928 · Cited by 2
Fear of cancer recurrence in patients undergoing germline genome sequencing
Bartley, N., Davies, G., Butow, P. N., Napier, C. E., Schlub, T. E., Ballinger, M. L., Thomas, D. M., Juraskova, I., Meiser, B., & Best, M. C. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06311-9 · Cited by 2
García, D. M. J., Vázquez-Esseso, M. B., Gálvez‐Hernández, C. L., Bazan, J., & Simard, S. (2024) · Anales de Psicología · doi:10.6018/analesps.590721 · Cited by 2
“Variables such as age, number of children, type of treatment and time of diagnosis have been related to greater fear of recurrence (Simard et al., 2013; Fang, Fetzer, Lee & Kuo, 2018; Koch-Gallenkamp et al., 2016; Krok-Schoen et al., 2018).”
BackgroundSheng, Y., Li, Q., Shen, F., Hu, L., Li, J., Wang, Q., & Li, H. (2025) · Cancer Nursing · doi:10.1097/ncc.0000000000001442 · Cited by 2
Communication and fear of cancer recurrence in colorectal cancer survivors and their partners
Catzen, H. Z., Abrahamse, P. H., Ward, K. C., Hawley, S. T., & Veenstra, C. M. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09630-3 · Cited by 3
“FCR has been reported to be common among CRC survivors [5], persist years into survivorship, and negatively impact survivors’ quality of life [6, 7, 38].”
Research Status of Fear of Cancer Recurrence in Breast Cancer Patients
Ding, Y., Zhang, L., Zhang, L., & Zhong, Q. (2024) · Journal of Cancer Therapy · doi:10.4236/jct.2024.159030 · Cited by 1
Liang, W., Pang, Y., Lin, J., Liu, J., & Liang, W. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1676894 · Cited by 1
Social Determinants and Psychosocial Factors That Impact on Health Status
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4869-1 · Cited by 1
Beyond tumor biology: nursing interventions for psychological and immune health in cancer patients
Gou, Y. R., Gu, H., & Wang, L. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10574-5 · Cited by 1
“Cancer stage generally shows minimal association with FCR. Profiles of FCR range from mild to severe, with social isolation, lower education, and chemotherapy linked to higher fears [28, 30, 31].”
Wheeler, C., & O'Rourke, N. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-11180-1 · Cited by 1
“Koch et al. [52] and Koch-Gallenkamp et al. [53] each describe separate cohorts from the same study with the first reporting on breast cancer and the second study including breast, colorectal and prostate but we have separated the data of the second paper to just the colorectal and prostate…”
Andritsch, E., & Traun-Vogt, G. (2019) · Springer eBooks · doi:10.1007/978-3-662-57982-4_9 · Cited by 1
Fernández, C., González-Fernández, S., & Pedrosa, I. (2019) · Anales de Psicología · doi:10.6018/analesps.336311 · Cited by 2
Yoon, H. S., & Ryu, E. (2022) · Korean Journal of Adult Nursing · doi:10.7475/kjan.2022.34.4.369 · Cited by 1
Metadata
- Authors
- Koch-Gallenkamp, L., Bertram, H., Eberle, A., Holleczek, B., Schmid-Höpfner, S., Waldmann, A., Zeissig, S. R., Brenner, H., & Arndt, V.
- Affiliations
- Leibniz Institute for Prevention Research and Epidemiology - BIPS (DE)
- Krebsregister Saarland (DE)
- University of Lübeck (DE)
- German Cancer Research Center (DE)
- ORCID
- Venue
- Health Psychology
- Published
- 2016-12
- Volume
- 35
- Issue
- 12
- Pages
- 1329-1333
- ISSN
- 0278-6133 (ISSN-L)
- 1930-7810
- OpenAlex
- W2355234226
- Cited by
- 107
- References
- 15
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 9 · 2023: 16 · 2022: 14 · 2021: 10 · 2020: 15 · 2019: 12 · 2018: 11 · 2017: 5
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Health Psychology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- German Cancer Aid (108262)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- fear of recurrence, long-term cancer survivors, breast cancer, colorectal cancer, prostate cancer, social support, social isolation, sex differences, age, time since diagnosis, psychological distress
- MeSH terms
- Cross-Sectional Studies, Fear, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Surveys and Questionnaires, Social Support, Time Factors, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.